Granted Patent
Utility
US 6,162,432 · App. 08/466,465
Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
Inventors:
Barbara P. Wallner, Kevin D. Cooper
Patented Case
View Patent ↗
Granted: Dec 19, 2000
Filed: Jun 6, 1995
Inventors
Barbara P. Wallner
Kevin D. Cooper
Assignees (at issue)
Biogen Inc.
THE REGENTS OF THE UNIVERSITY OF MICHIGAN
This patent predates the USPTO's electronic file wrapper — prosecution documents from this era exist only in the Patent Office's paper records. A certified copy of the file history can be ordered from the USPTO's paper archives.